A detailed history of Convergence Financial, LLC transactions in Haleon PLC stock. As of the latest transaction made, Convergence Financial, LLC holds 10,958 shares of HLN stock, worth $106,730. This represents 0.02% of its overall portfolio holdings.

Number of Shares
10,958
Previous 18,605 41.1%
Holding current value
$106,730
Previous $154 Million 24.56%
% of portfolio
0.02%
Previous 0.04%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$8.32 - $10.7 $63,623 - $81,822
-7,647 Reduced 41.1%
10,958 $116 Million
Q2 2024

Oct 23, 2024

BUY
$8.01 - $8.64 $149,026 - $160,747
18,605 New
18,605 $154 Million

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $45B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Convergence Financial, LLC Portfolio

Follow Convergence Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Convergence Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Convergence Financial, LLC with notifications on news.